XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,790) $ (19,126)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 83,782 74,258
Deferred income taxes (10,259) 9,168
Loss on extinguishment of debt 0 1,700
Impairment and lease termination charges 7,255 854
(Gain)/loss on disposal of property and equipment (244) 157
Gain on sale-leaseback (4,311) 0
Share-based compensation 13,318 16,973
Change in accounts and notes receivable allowances 378 133
Inventory write-off 388 2,983
Other 804 (315)
Change in operating assets and liabilities, excluding business acquisitions and foreign currency translation adjustments (12,591) 12,003
Net cash provided by operating activities 70,730 98,788
CASH FLOWS USED FOR INVESTING ACTIVITIES:    
Purchase of property and equipment (75,002) (83,485)
Proceeds from disposals of assets 856 202
Proceeds from sale-leaseback 5,700 0
Acquisition of shops and franchise rights from franchisees, net of cash acquired (17,335) (33,888)
Purchase of equity method investment (989) 0
Other investing activities (931) 455
Net cash used for investing activities (87,701) (116,716)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of debt 121,500 670,000
Repayment of long-term debt and lease obligations (70,180) (1,115,910)
Payment of financing costs 0 1,700
Proceeds from structured payables 219,459 194,927
Payments on structured payables (211,778) (223,063)
Payment of contingent consideration related to a business combination (900) 0
Capital contribution by shareholders, net of loans issued (288) 120,532
Proceeds from IPO, net of underwriting discounts (excluding unpaid issuance costs) 0 527,329
Payments of issuance costs in connection with IPO (12,458) 0
Proceeds from sale of noncontrolling interest in subsidiary 410 53,337
Distribution to shareholders (17,570) (42,334)
Payments for repurchase and retirement of common stock (2,425) (138,501)
Distribution to noncontrolling interest (11,525) (17,257)
Net cash provided by financing activities 14,245 27,360
Effect of exchange rate changes on cash, cash equivalents and restricted cash (7,967) (1,827)
Net (decrease)/increase in cash, cash equivalents and restricted cash (10,693) 7,605
Cash, cash equivalents and restricted cash at beginning of period 39,192 37,483
Cash, cash equivalents and restricted cash at end of period 28,499 45,088
Supplemental schedule of non-cash investing and financing activities:    
Increase in accrual for property and equipment 16,272 3,137
Stock issuance under shareholder notes 547 446
Accrual for distribution to shareholders (5,860) (5,853)
Accrual for repurchase and retirement of common stock 0 (188)
Accrual for distribution to noncontrolling interest 0 (5,056)
Reconciliation of cash, cash equivalents and restricted cash at end of period:    
Cash and cash equivalents 28,096 44,895
Restricted cash 403 193
Total cash, cash equivalents and restricted cash $ 28,499 $ 45,088